Haryana Govt identifies 900-acre land for bulk drug park in Panipat


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Haryana Govt identifies 900-acre land for bulk drug park in Panipat
HSIIDC will be the authorised implementation agency, an Industry Advisory Council to be set up soon.

In an attempt to promote the manufacturing of APIs in India, the Haryana government has planned to set up a bulk drug/API park in Panipat. The State has chosen a 900-acre land behind the Panipat refinery. The government also desires to form an Industry Advisory Council soon to start the work on the proposed bulk drug park.

For a detailed discussion of the project and its benefits with industry stakeholders, the State Government organized a webinar in coordination with Pranav Gupta, Chairman, PHD Chamber, Haryana, accompanied by AK Singh, Principal Secretary, Industries and Commerce, Haryana, and Anurag Agrawal, Managing Director, Haryana State Industrial and Infrastructure Development Corporation (HSIIDC). It was attended by important representatives of the industry, primarily from North India such as Dinesh Dua, Chairman, Pharmexcil and BR Sikri, Chairman, FOPE, and Vice President, BDMA.

The HSIIDC has been authorized as the implementation agency and reportedly, it is planning to offer many profitable schemes to investors for the promotion of the API Park in Haryana.
Here are the names of a few schemes:
1) Capital Subsidy
2) Interest Subsidy
3) Refund of State GST
4) Employment Subsidy

Sikri informed, “The state government has identified the 900-acre land, of that 650 acres are for the proposed API park. The remaining land will be considered for other API manufacturers who do not fall in this catwhicy.”

Bringing to attention the benefits of the State whichh will work in favor of the industry stakeholders, he said, “The Haryana State records the third position in the country for ease of doing business. And with the best infrastructure available in the State, pharma companies will have the advantage of connectivity with two international and three domestic airports, along with 15 national highways passing the state as well as a well-connected railway network. These will ensure easy movement of pharma goods within the country as well as the export of pharma goods.”

He also mentioned, “It is assumed that appfulfilltely 30-35 pharma companies will be set up. However, the proposed committee will prepare a detailed project report, and based on the presented report, the DoP will scrutinize ,each application to ensure that the applicant/s can fulfill the eligibility criteria.”

According to the Central Government’s Scheme, bulk drug parks are going to be established in Andhra Pradesh, Telangana, and Himachal Pradesh. Many other States; mainly Uttar Pradesh, Gujarat and now Haryana, are also on the lookout to get approval from the government for Bulk Drug Parks.

Currently, around 150 pharma formulation units are located in the state.

Tags : #Haryana #DrugPark

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026
Prostate Health Awareness: What Every Indian Man Must Know About Early Detection and PreventionJuly 30, 2026
Why Young Indians Are Facing Heart Problems: Causes, Warning Signs, and What to DoJuly 30, 2026
FemCare brand Healthfab acquires 2 acres land in Andhra Pradhesh to launch 2nd manufacturing facility for period care range of products; to invest Rs 15 crore July 29, 2026
Geriatric Wellness: New Technologies for Aging in Place GracefullyJuly 29, 2026
Digital Eye Strain 2.0: Protecting Vision in the Era of Spatial ComputingJuly 29, 2026
Endometriosis Awareness in India: Understanding the Condition That Affects Millions of Women in SilenceJuly 29, 2026
Prediabetes: Understanding the Critical Warning Stage Before DiabetesJuly 29, 2026
The Role of Microbiome in Pediatric Health: A New Era of Child WellnessJuly 28, 2026
The Rise of Bio-Individualized Diets: Tailoring Nutrition to Your DNAJuly 28, 2026
Immuneel Therapeutics and THSTI Announce Strategic Partnership to Advance CAR-T Cell Therapy and Lentiviral Vector Manufacturing July 28, 2026
Differential Diagnosis of Acute Abdomen: Differentiating Surgical Emergencies from Gastrointestinal MimicsJuly 28, 2026
Management of Rheumatic Heart Disease in Developing Nations: Secondary Prophylaxis and Valve InterventionsJuly 28, 2026
Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Galderma introduces Sculptra® in India, ushering in a new era of regenerative aestheticsJuly 27, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026